Cited by 66Fibromyalgia and Chronic Fatigue Syndrome ResearchPain Mechanisms and TreatmentsPsychosomatic Disorders and Their Treatments

Cornea nerve fiber quantification and construction of phenotypes in patients with fibromyalgia

Open access
Oudejans, Linda, He, Xuan, Niesters, Marieke, Dahan, Albert, Brines, Michael, van Velzen, Monique·2016·Scientific Reports

Abstract

Cornea confocal microscopy (CCM) is a novel non-invasive method to detect small nerve fiber pathology. CCM generally correlates with outcomes of skin biopsies in patients with small fiber pathology. The aim of this study was to quantify the morphology of small nerve fibers of the cornea of patients with fibromyalgia in terms of density, length and branching and further phenotype these patients using standardized quantitative sensory testing (QST). Small fiber pathology was detected in the cornea of 51% of patients: nerve fiber length was significantly decreased in 44% of patients compared to age- and sex-matched reference values; nerve fiber density and branching were significantly decreased in 10% and 28% of patients. The combination of the CCM parameters and sensory tests for central sensitization, (cold pain threshold, mechanical pain threshold, mechanical pain sensitivity, allodynia and/or windup), yielded four phenotypes of fibromyalgia patients in a subgroup analysis: one group with normal cornea morphology without and with signs of central sensitization and a group with abnormal cornea morphology parameters without and with signs of central sensitization. In conclusion, half of the tested fibromyalgia population demonstrates signs of small fiber pathology as measured by CCM. The four distinct phenotypes suggest possible differences in disease mechanisms and may require different treatment approaches.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/srep23573

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The lack of correlation between quantitative small fiber reduction and dysfunction in QST, pleasant touch test, and questionnaire data was also reported.

    “The lack of correlation between quantitative small fiber reduction and dysfunction in the remaining small fiber tests, namely QST and pleasant touch test, as well as questionnaire data was also reported.15,27,33”

    From Pain and small fiber pathology in men with fibromyalgia syndrome (2024) · cites this paper as [33]

    The Results section ('Correlations and subgroup analysis'; page unavailable) reports no significant correlations between corneal nerve morphology and QST or questionnaire scores. The paper does not report a pleasant-touch test or a correlation involving one, so that part of the attributed claim is unsupported. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • An earlier CCM study in a predominantly female FMS cohort showed loss of corneal nerve fibers but no correlation between abnormal corneal morphology and QST, WPI, and disease duration.

    “This confirms the findings of an earlier study using CCM to construct phenotypes in a cohort of predominantly female patients with FMS,33 where the authors showed a loss of corneal nerve fibers but no correlation between abnormal corneal morphology and QST, WPI, and disease duration.”
  • In previous studies, FMS subgroups have been defined based on extent of alterations in small fibers in skin and cornea, but hardly any male patients were included.

    “In previous studies, FMS subgroups have been defined based on the extent of alterations in small fibers in skin and cornea33; however, hardly any male patients were included.”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 41

  1. Schmidt-Wilcke T. & Clauw D. J. Fibromyalgia: from pathophysiology to therapy. Nature reviews. Rheumatology 7, 518– 527, doi: 10.1038/nrrheum.2011.98 (2011). 21769128 · DOI
  2. Jensen K. B. et al. Evidence of dysfunctional pain inhibition in Fibromyalgia reflected in rACC during provoked pain. Pain 144, 95– 100, doi: 10.1016/j.pain.2009.03.018 (2009). 19410366 · DOI · Paper page
  3. Lautenbacher S. & Rollman G. B. Possible deficiencies of pain modulation in fibromyalgia. The Clinical journal of pain 13, 189– 196 (1997). 9303250
  4. Caro X. J. & Winter E. F. Evidence of abnormal epidermal nerve fiber density in fibromyalgia: clinical and immunologic implications. Arthritis Rheumatol 66, 1945– 1954, doi: 10.1002/art.38662 (2014). 24719395 · DOI · Paper page
  5. Doppler K., Rittner H. L., Deckart M. & Sommer C. Reduced dermal nerve fiber diameter in skin biopsies of patients with fibromyalgia. Pain 156, 2319– 2325, doi: 10.1097/j.pain.0000000000000285 (2015). 26164586 · DOI · Paper page
  6. Giannoccaro M. P., Donadio V., Incensi A., Avoni P. & Liguori R. Small nerve fiber involvement in patients referred for fibromyalgia. Muscle & nerve 49, 757– 759, doi: 10.1002/mus.24156 (2014). 24469976 · DOI · Paper page
  7. Oaklander A. L., Herzog Z. D., Downs H. M. & Klein M. M. Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia. Pain 154, 2310– 2316, doi: 10.1016/j.pain.2013.06.001 (2013). 23748113 PMC3845002 · DOI · Paper page
  8. Ramirez M. et al. Small fiber neuropathy in women with fibromyalgia. An in vivo assessment using corneal confocal bio-microscopy. Seminars in arthritis and rheumatism 45, 214– 219, doi: 10.1016/j.semarthrit.2015.03.003 (2015). 26094164 · DOI · Paper page
  9. Uceyler N. et al. Small fibre pathology in patients with fibromyalgia syndrome. Brain: a journal of neurology 136, 1857– 1867, doi: 10.1093/brain/awt053 (2013). 23474848 · DOI · Paper page
  10. Serra J. et al. Hyperexcitable C nociceptors in fibromyalgia. Annals of neurology 75, 196– 208, doi: 10.1002/ana.24065 (2014). 24243538 · DOI · Paper page
  11. Clauw D. J. What is the meaning of “small fiber neuropathy” in fibromyalgia? Pain 156, 2115– 2116, doi: 10.1097/j.pain.0000000000000311 (2015). 26307862 · DOI
  12. Uceyler N. & Sommer C. Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia. Pain 154, 2569, doi: 10.1016/j.pain.2013.06.037 (2013). 23811315 · DOI
  13. Wopking S. et al. Significant difference between three observers in the assessment of intraepidermal nerve fiber density in skin biopsy. BMC Neurol 9, 13, doi: 10.1186/1471-2377-9-13 (2009). 19335896 PMC2672925 · DOI
  14. Petropoulos I. N. et al. Corneal nerve loss detected with corneal confocal microscopy is symmetrical and related to the severity of diabetic polyneuropathy. Diabetes Care 36, 3646– 3651, doi: 10.2337/dc13-0193 (2013). 23877983 PMC3816900 · DOI
  15. Tavakoli M. et al. Corneal confocal microscopy: a novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy. Diabetes Care 33, 1792– 1797, doi: 10.2337/dc10-0253 (2010). 20435796 PMC2909064 · DOI
  16. Ziegler D. et al. Early detection of nerve fiber loss by corneal confocal microscopy and skin biopsy in recently diagnosed type 2 diabetes. Diabetes 63, 2454– 2463, doi: 10.2337/db13-1819 (2014). 24574045 · DOI
  17. Tavakoli M. et al. Normative values for corneal nerve morphology assessed using corneal confocal microscopy: a multinational normative data set. Diabetes Care 38, 838– 843, doi: 10.2337/dc14-2311 (2015). 25633665 PMC4407754 · DOI · Paper page
  18. Arendt-Nielsen L. & Yarnitsky D. Experimental and clinical applications of quantitative sensory testing applied to skin, muscles and viscera. The journal of pain: official journal of the American Pain Society 10, 556– 572, doi: 10.1016/j.jpain.2009.02.002 (2009). 19380256 · DOI
  19. Woolf C. J. Central sensitization: implications for the diagnosis and treatment of pain. Pain 152, S2– 15, doi: 10.1016/j.pain.2010.09.030 (2011). 20961685 PMC3268359 · DOI · Paper page
  20. Malik R. A. et al. Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients. Diabetologia 46, 683– 688, doi: 10.1007/s00125-003-1086-8 (2003). 12739016 · DOI
  21. Tavakoli M. & Malik R. A. Corneal confocal microscopy: a novel non-invasive technique to quantify small fibre pathology in peripheral neuropathies. J Vis Exp, doi: 10.3791/2194 (2011). PMC3182640 21248693 · DOI
  22. Tavakoli M. et al. Corneal confocal microscopy: a novel noninvasive means to diagnose neuropathy in patients with Fabry disease. Muscle & nerve 40, 976– 984, doi: 10.1002/mus.21383 (2009). 19902546 · DOI
  23. Kosmidis M. L. et al. Reduction of Intraepidermal Nerve Fiber Density (IENFD) in the skin biopsies of patients with fibromyalgia: a controlled study. J Neurol Sci 347, 143– 147, doi: 10.1016/j.jns.2014.09.035 (2014). 25304055 · DOI · Paper page
  24. Klauenberg S. et al. Depression and changed pain perception: hints for a central disinhibition mechanism. Pain 140, 332– 343, doi: 10.1016/j.pain.2008.09.003 (2008). 18926637 · DOI
  25. Blumenstiel K. et al. Quantitative sensory testing profiles in chronic back pain are distinct from those in fibromyalgia. The Clinical journal of pain 27, 682– 690, doi: 10.1097/AJP.0b013e3182177654 (2011). 21487289 · DOI
  26. Rolke R. et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain 123, 231– 243, doi: 10.1016/j.pain.2006.01.041 (2006). 16697110 · DOI
  27. Lang P. M. et al. Sensory neuropathy and signs of central sensitization in patients with peripheral arterial disease. Pain 124, 190– 200, doi: 10.1016/j.pain.2006.04.011 (2006). 16716518 · DOI
  28. Desmeules J. A. et al. Neurophysiologic evidence for a central sensitization in patients with fibromyalgia. Arthritis and rheumatism 48, 1420– 1429, doi: 10.1002/art.10893 (2003). 12746916 · DOI
  29. Fayed N. et al. Localized 1H-NMR spectroscopy in patients with fibromyalgia: a controlled study of changes in cerebral glutamate/glutamine, inositol, choline, and N-acetylaspartate. Arthritis research & therapy 12, R134, doi: 10.1186/ar3072 (2010). 20609227 PMC2945024 · DOI
  30. Gracely R. H. & Ambrose K. R. Neuroimaging of fibromyalgia. Best practice & research. Clinical rheumatology 25, 271– 284, doi: 10.1016/j.berh.2011.02.003 (2011). 22094201 · DOI
  31. Jensen K. B. et al. Patients with fibromyalgia display less functional connectivity in the brain’s pain inhibitory network. Molecular pain 8, 32, doi: 10.1186/1744-8069-8-32 (2012). 22537768 PMC3404927 · DOI
  32. Napadow V. & Harris R. E. What has functional connectivity and chemical neuroimaging in fibromyalgia taught us about the mechanisms and management of ‘centralized’ pain? Arthritis research & therapy 16, 425 (2014). 25606591 PMC4289059
  33. Clauw D. J. Diagnosing and treating chronic musculoskeletal pain based on the underlying mechanism(s). Best Pract Res Cl Rh 29, 6– 19, doi: 10.1016/j.berh.2015.04.024 (2015). 26266995 · DOI · Paper page
  34. Ablin J. N. & Buskila D. Update on the genetics of the fibromyalgia syndrome. Best practice & research. Clinical rheumatology 29, 20– 28, doi: 10.1016/j.berh.2015.04.018 (2015). 26266996 · DOI
  35. Desmeules J. et al. Central pain sensitization, COMT Val158Met polymorphism, and emotional factors in fibromyalgia. The journal of pain: official journal of the American Pain Society 15, 129– 135, doi: 10.1016/j.jpain.2013.10.004 (2014). 24342707 · DOI
  36. Heij L. et al. Safety and efficacy of ARA 290 in sarcoidosis patients with symptoms of small fiber neuropathy: a randomized, double-blind pilot study. Mol Med 18, 1430– 1436, doi: 10.2119/molmed.2012.00332 (2012). 23168581 PMC3563705 · DOI
  37. Wolfe F. et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheumatol 33, 160– 172 (1990). 2306288
  38. Chen X. et al. Small Nerve Fiber Quantification in the Diagnosis of Diabetic Sensorimotor Polyneuropathy: Comparing Corneal Confocal Microscopy With Intraepidermal Nerve Fiber Density. Diabetes Care, doi: 10.2337/dc14-2422 (2015). PMC4439535 25795415 · DOI
  39. Petropoulos I. N. et al. Rapid automated diagnosis of diabetic peripheral neuropathy with in vivo corneal confocal microscopy. Investigative ophthalmology & visual science 55, 2071– 2078, doi: 10.1167/iovs.13-13787 (2014). 24569580 PMC3979234 · DOI
  40. Hoitsma E., De Vries J. & Drent M. The small fiber neuropathy screening list: Construction and cross-validation in sarcoidosis. Respiratory medicine 105, 95– 100, doi: 10.1016/j.rmed.2010.09.014 (2011). 20889323 · DOI
  41. Magerl W. et al. Reference data for quantitative sensory testing (QST): refined stratification for age and a novel method for statistical comparison of group data. Pain 151, 598– 605, doi: 10.1016/j.pain.2010.07.026 (2010). 20965658 · DOI

Cited by

Sorted by citations

Authors
Oudejans, L., He, X., Niesters, M., Dahan, A., Brines, M., & van Velzen, M.
Affiliations
  • Leiden University Medical Center (NL)
  • Araim Pharmaceuticals (United States) (US)
Corresponding author
Dahan, Albert
Venue
Scientific Reports
Published
2016-03-23
Volume
6
Issue
1
Pages
23573-23573
ISSN
2045-2322 (ISSN-L)
OpenAlex
W2329592746
Cited by
66
References
3
Citations by year
2026: 5 · 2025: 11 · 2024: 3 · 2023: 6 · 2022: 8 · 2021: 5 · 2020: 11 · 2019: 7 · 2018: 4 · 2017: 5 · 2016: 1
FWCI
5.04
Type
journal article
Language
en
Open access
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Leiden Repository (Leiden University) (submittedVersion)
Funders
University of Manchester
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
  • Health Sciences › Medicine › Physiology › Pain Mechanisms and Treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
Keywords
fibromyalgia, corneal nerve fiber density, central sensitization, quantitative sensory testing, phenotypes, allodynia, cold pain threshold, mechanical pain sensitivity, wind-up
MeSH terms
Adult, Cornea, Female, Fibromyalgia, Humans, Male, Middle Aged, Nerve Fibers, Microscopy, Confocal, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review